Dennis L Broyles
Overview
Explore the profile of Dennis L Broyles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker T, Bird C, Broyles D, Klause U
Diagnostics (Basel)
. 2025 Jan;
15(1.
PMID: 39795623
: The current gold standards for diagnosing acute kidney injury (AKI) are an increase in serum creatinine and a decrease in urine output, which are inadequate for rapid diagnosis. Neutrophil...
2.
Katz-Greenberg G, Malinchoc M, Broyles D, Oxman D, Hamrahian S, Maarouf O
Kidney360
. 2022 Oct;
3(9):1502-1510.
PMID: 36245663
Background: Acute kidney injury (AKI) is most commonly caused by tubular injury and is associated with a wide variety of critical illnesses. It is well known that urinary biomarkers can...
3.
Baker V, Glassner M, Doody K, Schnell V, Gracia C, Shin S, et al.
Fertil Steril
. 2021 Apr;
116(2):575-582.
PMID: 33812650
Objective: To evaluate the diagnostic performance of the antimüllerian hormone (AMH) level determined using the Access AMH assay for predicting poor ovarian response (POR) defined as ≤4 oocytes retrieved, including...
4.
Baker V, Gracia C, Glassner M, Schnell V, Doody K, Coddington C, et al.
Fertil Steril
. 2018 Jul;
110(3):506-513.e3.
PMID: 29960708
Objective: To evaluate a new fully automated antimüllerian hormone (AMH) assay for prediction of poor ovarian response (POR) to ovarian stimulation defined as four or fewer oocytes retrieved. Design: Prospective...
5.
Gracia C, Shin S, Prewitt M, Chamberlin J, Lofaro L, Jones K, et al.
J Assist Reprod Genet
. 2018 Mar;
35(5):777-783.
PMID: 29536384
Background: AMH is widely used for assessing ovarian reserve, and it is particularly convenient, because it is thought to have minimal variability throughout the menstrual cycle. However, studies assessing the...
6.
White J, Shenoy B, Tutrone R, Karsh L, Saltzstein D, Harmon W, et al.
Prostate Cancer Prostatic Dis
. 2017 Nov;
21(1):78-84.
PMID: 29158509
Background: Deciding when to biopsy a man with non-suspicious DRE findings and tPSA in the 4-10 ng/ml range can be challenging, because two-thirds of such biopsies are typically found to...
7.
Loeb S, Shin S, Broyles D, Wei J, Sanda M, Klee G, et al.
BJU Int
. 2016 Oct;
120(1):61-68.
PMID: 27743489
Objective: To examine the use of the Prostate Health Index (PHI) as a continuous variable in multivariable risk assessment for aggressive prostate cancer in a large multicentre US study. Materials...
8.
Loeb S, Sanda M, Broyles D, Shin S, Bangma C, Wei J, et al.
J Urol
. 2014 Dec;
193(4):1163-9.
PMID: 25463993
Purpose: The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now commercially...
9.
Loeb S, Sokoll L, Broyles D, Bangma C, van Schaik R, Klee G, et al.
J Urol
. 2012 Dec;
189(5):1702-6.
PMID: 23206426
Purpose: Reported prostate specific antigen values may differ substantially among assays using Hybritech® or WHO standardization. The Beckman Coulter® Prostate Health Index and [-2]proPSA are newly approved serum markers associated...
10.
Sokoll L, Chan D, Klee G, Roberts W, van Schaik R, Arockiasamy D, et al.
Clin Chim Acta
. 2012 May;
413(15-16):1279-83.
PMID: 22542565
Background: Total PSA assays measure both complexed and non-complexed forms of PSA while free PSA assays only measure non-complexed forms. Free PSA is a mixture of isoforms including immature PSA...